Methods for individualising factor VIII dosing in prophylaxis-Reference-Cited by-同舟云学术

Methods for individualising factor VIII dosing in prophylaxis

Published:2014-06-24 Issue: Volume:93 Page:16-20
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Ar Muhlis Cem¹,Vaide Ines²,Berntorp Erik³,Björkman Sven⁴

Affiliation:

1. Department of Haematology; Istanbul University Cerrahpasa Medical Faculty; Istanbul Turkey

2. Department of Haematology; North Estonian Medical Centre; Tallinn Estonia

3. Lund University; Centre for Thrombosis and Haemostasis; Skåne University Hospital; Malmö Sweden

4. Department of Pharmaceutical Biosciences; Uppsala University; Uppsala Sweden

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12370/fullpdf

Reference31 articles.

1. Patterns of bleeding in adolescents with severe haemophilia A;Aronstam;BMJ,1979

2. The Orthopaedic Outcome Study Group. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs;Aledort;J Intern Med,1994

3. Haemophilia in Sweden VII. Incidence, treatment and prophylaxis of arthropathy and other musculoskeletal manifestations of haemophilia A and B;Ahlberg;Acta Orthop Scand,1965

4. Haemophilia prophylaxis in Sweden;Nilsson;Acta Paediatr Scand,1976

5. Prophylaxis of joint haemorrhages in haemophilia;Creveld;Acta Haematol,1971

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics of recombinant factor VIII in adults with severe hemophilia A: fixed-sequence single-dose study of octocog alfa, rurioctocog alfa pegol, and efanesoctocog alfa;Research and Practice in Thrombosis and Haemostasis;2023-05

2. Race, ethnicity, F8 variants, and inhibitor risk: analysis of the “My Life Our Future” hemophilia A database;Journal of Thrombosis and Haemostasis;2023-04

3. Clinical and laboratory presentation of von Willebrand disease: Experience from a single center in Saudi Arabia;Journal of Taibah University Medical Sciences;2023-04

4. Improved clinical outcome after PK-Guided Personalised Prophylaxis with my-PKFIT® in patients with hemophilia A without inhibitors;Medical Science and Discovery;2022-02-18

5. Individualized prophylactic treatment of patients with hemophilia A to improve effectiveness and optimize product consumption on the example of octocog alpha and rurioctocog alpha pegol. A systematic literature review;Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice;2021-08-13